Claudin 17 Antikörper (Middle Region)
-
- Target Alle Claudin 17 (CLDN17) Antikörper anzeigen
- Claudin 17 (CLDN17)
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human, Maus, Ratte, Hund, Rind (Kuh), Schwein
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Claudin 17 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Sequenz
- KQVQCTGSNE RAKAYLLGTS GVLFILTGIF VLIPVSWTAN IIIRDFYNPA
- Kreuzreaktivität (Details)
- Species reactivity (expected):Mouse, Rat, Dog, Pig, BovineSpecies reactivity (tested):Human
- Aufreinigung
- Purified using Protein A affinity column
- Immunogen
- The immunogen for anti-CLDN17 antibody: synthetic peptide directed towards the middle region of human CLDN17
- Top Product
- Discover our top product CLDN17 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Rekonstitution
- Add 100 μL of distilled water to a final concentration of 1 mg/mL.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store lyophilized at 2-8 °C or at -20 °C long term. After reconstitution store the antibody undiluted at 2-8 °C for up to one month or in aliquots at -20 °C long term.
-
- Target
- Claudin 17 (CLDN17)
- Andere Bezeichnung
- Claudin-17 / CLDN17 (CLDN17 Produkte)
- Synonyme
- CLDN17 antikoerper, Claudin-17 antikoerper, zgc:173444 antikoerper, claudin 17 antikoerper, CLDN17 antikoerper, cldn17 antikoerper, Cldn17 antikoerper
- Hintergrund
- CLDN17, clustered with CLDN8 at human chromosome 21q22.11, is a four-transmembrane protein with WWCC motif, defined by W-X(17-22)-W-X(2)-C-X(8-10)-C. It plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity.Synonyms: PRO1489, UNQ758
- Gen-ID
- 26285
- NCBI Accession
- NP_036263
- Pathways
- Cell-Cell Junction Organization, Hepatitis C
-